z-logo
open-access-imgOpen Access
Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein
Author(s) -
Yuan Dong,
Qingling Li
Publication year - 2022
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2022/4457740
Subject(s) - ipratropium bromide , budesonide , medicine , exacerbation , ipratropium , anesthesia , inhalation , vital capacity , bronchodilator , lung , asthma , lung function , diffusing capacity

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom